Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade

Authors:

Abstract
Rotavirus vaccines have oncolytic properties and can overcome resistance to anti–PD-(L)1/CTLA-4 via RIG-I activation upon intratumoral administration.
Funding Information
  • Ligue Contre le Cancer
  • Institut National Du Cancer (PRTK14_061)
  • Institut National Du Cancer (LYRICAN, INCa-DGOS-Inserm_12563)
  • Les 111 des Arts
  • Torocinelles
  • LabEx DEvweCAN (ANR-10-LABX-0061)
  • ALBEC
  • Institut d’Hématologie et d’Oncologie Pédiatrique

This publication has 37 references indexed in Scilit: